Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Mergers, Rhythm, Regeneron, & More 05/09/14 Boston
7 Takeaways From “What’s Hot in Boston Biotech” 04/22/14 Boston
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More 04/04/14 Boston
Foresite Capital Reloads With New $300M Late-Stage Biotech Fund 04/01/14 San Francisco
What’s Hot in Boston Biotech: Here’s the Agenda for April 16 03/27/14 Boston
East Coast Biotech Roundup: Dicerna, J&J, Neurophage, & More 01/31/14 Boston
Epizyme Heads Back to Wall Street, Plans $140M Raise 01/27/14 Boston
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More 01/10/14 Boston
Fresh from IPO, Five Prime Advances Arthritis and Cancer Drugs 12/19/13 San Francisco
East Coast Biotech Roundup: Juno, Editas, Celgene, & More 12/06/13 Boston
Celgene Plunks Down $177M Upfront for OncoMed’s Stem Cell Drugs 12/03/13 San Francisco
3 Life Sciences Companies That Are Built to Last 12/02/13 National
New Enterprise Associates Sets up Shop in Kendall Square 11/14/13 Boston
Xconomy Boston’s Top 10 Stories from Q3 2013: Editor’s Picks 09/30/13 Boston
Which VCs Are Poised to Profit From the Biotech IPO Boom? 09/09/13 National
Biotech and Fantasy Football Picks for Fall 2013 09/03/13 National
Syndax Pockets $26.6M For Final Stage Push With Cancer Drug 08/27/13 Boston
Who Should Biotech Pros Follow on Twitter? An Update for 2013 08/19/13 National
East Coast Life Sciences Roundup: Epizyme, Rodin, Ophthotech, & More 08/16/13 Boston
Epizyme Execs Share the Secret to a Successful IPO: PowerBars 08/15/13 Boston
Atlas Startup, Rodin, Hopes to Rewire Neurons to Improve Memory 08/12/13 Boston
East Coast Life Sciences Roundup: KiiLN, Celgene, Acceleron, & More 08/09/13 New York
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
Agios Prices Upsized IPO Above Range, Preps For Nasdaq Debut 07/24/13 Boston
The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts 07/22/13 National
U.S. Venture Activity Remains Steady as IPOs Rise in Second Quarter 07/16/13 National
East Coast Life Sciences Roundup: Celgene, Dunsire, Forma, & More 07/12/13 Boston
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
East Coast Life Sciences Roundup: Verdine, Vedanta, Alnylam, & More 07/05/13 Boston
Xconomy Boston’s Top 20 Stories of Q2 2013: Editor’s Picks 07/01/13 Boston
Page 1 of 3 next page »